IFN-beta induces caspase-mediated apoptosis by disrupting mitochondria in human advanced stage colon cancer cell lines
Related Experiment Video
Updated: Aug 24, 2026

Visualization of Inflammatory Caspases Induced Proximity in Human Monocyte-Derived Macrophages
Published on: April 6, 2022
Shin-Hun Juang1, Sung-Jen Wei, Yi-Mei Hung
1Cancer Research Cooperative Laboratory, NHRI, Taipei 100, ROC.
Abstract:
Various human colon cancer cell lines tested in vitro differed significantly in susceptibility to growth inhibition of recombinant human interferon-beta (rHuIFN-beta). Two p53-mutant lines, COH and CC-M2, derived from high-grade colon adenocarcinoma, showed signs of apoptosis after treatment with 250 IU/ml of HuIFN- beta in the culture medium. The similarly p53-mutated HT-29 line from a grade I adenocarcinoma showed no apoptosis, however, and only cell cycle G1/G0 or S phase retardation with 1000 IU/ml HuIFN-beta. After HuIFN-beta exposure, COH and CC-M2 cells showed increased levels of Fas and FasL proteins, alteration of mitochondrial membrane potential, and activation of caspase-9, caspase-8, and caspase-3 in a time-dependent manner. Treatment of COH and CC-M2 cells with anti-FasL antibodies or rFas/Fc fusion protein, however, could not prevent the apoptosis induced by HuIFN-beta. In contrast, cell-permeable specific inhibitors of the three caspases could inhibit the DNA fragmentation and cell death but not the mitochondrial membrane potential changes. Treatment with mitochondria-stabilizing reagents could significantly abrogate the apoptosis and caspase activation induced by HuIFN-beta. These results suggest that in COH and CC-M2 colon cancer cell lines, HuIFN-beta induces apoptosis mainly through mitochondrial membrane alteration and subsequent activation of the caspase cascade pathway, but not by the Fas/FasL interaction or the p53-dependent apoptotic mechanism.
Insights
Recombinant human interferon-beta (rHuIFN-beta) triggers apoptosis in specific colon cancer cells. This occurs via mitochondrial damage and caspase activation, independent of p53 or Fas/FasL pathways.
Area of Science:
- Oncology
- Cell Biology
- Immunology
Background:
- Human interferon-beta (HuIFN-beta) exhibits variable efficacy in inhibiting colon cancer cell growth.
- Colon cancer cell lines display differential responses to HuIFN-beta, influenced by p53 mutation status and tumor grade.
Purpose of the Study:
- To investigate the mechanisms by which recombinant human interferon-beta (rHuIFN-beta) induces apoptosis in p53-mutant colon cancer cell lines.
- To elucidate the role of p53, Fas/FasL pathway, and mitochondrial integrity in HuIFN-beta-mediated apoptosis.
Main Methods:
- In vitro treatment of human colon cancer cell lines (COH, CC-M2, HT-29) with varying concentrations of HuIFN-beta.
- Analysis of apoptosis, cell cycle, Fas/FasL protein levels, mitochondrial membrane potential, and caspase activation (caspase-9, -8, -3).
- Use of specific inhibitors and blocking antibodies to dissect apoptotic pathways.
Main Results:
- HuIFN-beta induced apoptosis in p53-mutant COH and CC-M2 cells, but only cell cycle arrest in HT-29 cells.
- Apoptosis in COH and CC-M2 cells involved increased Fas/FasL, altered mitochondrial potential, and caspase cascade activation.
- Fas/FasL blocking agents did not prevent apoptosis, while caspase inhibitors blocked DNA fragmentation but not mitochondrial changes.
- Mitochondria-stabilizing reagents abrogated HuIFN-beta-induced apoptosis and caspase activation.
Conclusions:
- HuIFN-beta induces apoptosis in susceptible colon cancer cells primarily through mitochondrial membrane destabilization and subsequent caspase cascade activation.
- The apoptotic mechanism is independent of the p53 status and Fas/FasL signaling pathway in these cell lines.
- Targeting mitochondrial pathways may enhance HuIFN-beta's therapeutic potential in colon cancer treatment.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Caspases
The Extrinsic Apoptotic Pathway
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.

